Extensive evidence suggests that saturated FAs represent an endogenous danger in the first hit of NASH by upregulating the inflammasome and thus sensitizing to second hits such as LPS for IL-1β release [100]. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.